Skip to main content

Advertisement

Log in

Comparative study between topical steroid alone versus combined fractional Erbium:YAG laser with topical steroid in treatment of alopecia areata

  • Study Protocol
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

AA is a common autoimmune skin disease that causes hair loss on the scalp and sometimes other areas of the body. New therapy approaches for alopecia areata are emerging, with the goal of improving clinical outcomes. In this study, the effects of topical steroids against fractional Er:YAG laser followed by topical steroids in the treatment of alopecia areata will be compared. A total of 30 participants with alopecia areata were included in the study. Each patient's lesions were treated with one of two methods: topical clobetasol propionate or fractional Er:YAG laser followed by topical clobetasol propionate. SALT score, patient satisfaction, and dermoscopic imaging were used to evaluate therapeutic response. Both treatment modalities showed a significant clinical improvement in alopecia areata with a statistically significant reduction in the SALT score. The SALT score was more evident in the laser-steroid group. On comparing the dermoscopy findings in both treated areas before and after treatment, a significant reduction was found regarding all dermoscopic findings of alopecia areata in both modalities. Combining fractional Er:YAG laser with topical steroids is found to be a safe treatment modality and more effective than topical steroids in alopecia areata.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Tomaszewska K, Kozłowska M, Kaszuba A, Lesiak A, Narbutt J, Zalewska-Janowska A (2020) Increased serum levels of IFN-γ, IL-1β, and IL-6 in patients with alopecia areata and nonsegmental vitiligo. Oxid Med Cell Longev 3:5693572

    Google Scholar 

  2. Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J (2018) Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol 78(1):1–12

    Article  PubMed  Google Scholar 

  3. Lee S, Lee WS (2017) Management of alopecia areata: updates and algorithmic approach. J Dermatol 44(11):1199–1211

    Article  PubMed  Google Scholar 

  4. Stacey SK, McEleney M (2021) Topical corticosteroids: choice and application. Am Fam Physician 103(6):337–343

    PubMed  Google Scholar 

  5. Ito T (2012) Advances in the management of alopecia areata. J Dermatol 39(1):11–17

    Article  CAS  PubMed  Google Scholar 

  6. Molinelli E, Campanati A, Brisigotti V, Sapigni C, Paolinelli M, Offidani A (2020) Efficacy and safety of topical calcipotriol 0.005% versus topical clobetasol 0.05% in the management of alopecia areata: an intrasubject pilot study. Dermatol Ther 10(3):515–521

    Article  Google Scholar 

  7. Boechat A, Torezan L, Osório N (2016) Lasers, Lights, and Related Technologies in Cosmetic Dermatology. In: Issa M, Tamura B (eds) Daily Routine in Cosmetic Dermatology. Clinical Approaches and Procedures in Cosmetic Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-20250-1_30-1

  8. Lew BL, Shin MK, Sim WY (2009) Acute diffuse and total alopecia: a new subtype of alopecia areata with a favorable prognosis. J Am Acad Dermatol 60:85–93

    Article  PubMed  Google Scholar 

  9. Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP (2017) Alopecia areata. Nat Rev Dis Primers 3:17011

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lee JH, Eun SH, Kim SH, Ju HJ, Kim GM, Bae JM (2020) Excimer laser/light treatment of alopecia areata: a systematic review and meta-analyses. Photodermatol Photoimmunol Photomed 36(6):460–469

    Article  PubMed  Google Scholar 

  11. Vazquez-Herrera NE, Tosti A (2020) Alopecia areata: clinical treatment. Hair and scalp treatments. Springer, Cham, pp 109–124

    Chapter  Google Scholar 

  12. Yoo KH et al (2010) Treatment of alopecia areata with fractional photothermolysis laser. Int J Dermatol 49(7):845

    PubMed  Google Scholar 

  13. Cho S et al (2013) Clinical effects of non-ablative and ablative fractional lasers on various hair disorders: a case series of 17 patients. J Cosmet Laser Therapy 15(2):74–79

    Article  Google Scholar 

  14. Majid I, Jeelani S, Imran S (2018) Fractional carbon dioxide laser in combination with topical corticosteroid application in resistant alopecia areata: a case series. J Cutan Aesthet Surg 11:217–221

    Article  PubMed  PubMed Central  Google Scholar 

  15. Yalici-Armagan B, Elcin G (2016) The effect of neodymium: yttrium aluminum garnet and fractional carbon dioxide lasers on alopecia areata: a prospective controlled clinical trial. Dermatol Surg 42:500–506

    Article  CAS  PubMed  Google Scholar 

  16. Ke J, Guan H, Li S, Xu L, Zhang L, Yan Y (2015) Erbium:YAG laser (2,940 nm) treatment stimulates hair growth through upregulating Wnt 10b and β-catenin expression in C57BL/6 mice. Int J Clin Exp Med 8(11):20883–20889

    CAS  PubMed  PubMed Central  Google Scholar 

  17. El-Husseiny R, Elframawy S, Abdallah M (2020) Comparative study between fractional carbon dioxide laser vs intralesional steroid injection in treatment of alopecia areata. Dermatol Ther 33(4):e13742

    Article  CAS  PubMed  Google Scholar 

  18. Tanakol A, Oba MC, Uzuncakmak TK, Askin O, Kutlubay Z (2020) Treatment of alopecia areata with 2940-nm fractional erbium:yttrium-aluminum-garnet laser. Dermatol Ther 33(6):e13978

    Article  PubMed  Google Scholar 

  19. Fukuyama M, Ito T, Ohyama M (2022) Alopecia areata: current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines. J Dermatol 49(1):19–36

    Article  CAS  PubMed  Google Scholar 

  20. Inui S, Nakajima T, Nakagawa K, Itami S (2008) Clinical significance of dermoscopy in alopecia areata: analysis of 300 cases. Int J Dermatol 47(7):688–693

    Article  PubMed  Google Scholar 

  21. Ganjoo S, Thappa DM (2013) Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata. Indian J Dermatol Venereol Leprol 79:408–417

    Article  PubMed  Google Scholar 

Download references

Funding

This is a contributors' own work, and the working team didn't receive any funds.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shady Mahmoud Attia Ibrahim.

Ethics declarations

Conflict of interest

Authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shokeir, H.A., Yousry, A. & Ibrahim, S.M.A. Comparative study between topical steroid alone versus combined fractional Erbium:YAG laser with topical steroid in treatment of alopecia areata. Arch Dermatol Res 315, 241–247 (2023). https://doi.org/10.1007/s00403-022-02417-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-022-02417-0

Keywords

Navigation